Blog

Gene therapy improves immunity in babies with ‘bubble boy’ disease – Medical Xpress


Medical Xpress

Gene therapy improves immunity in babies with 'bubble boy' disease
Medical Xpress
Ewelina Mamcarz, M.D., presents research at the 2017 ASH conference that indicates that the St. Jude XSCID gene therapy has been well tolerated and effective for infants as young as 2 months old. Credit: Peter Barta / St. Jude Children's Research

and more »

2017-12-09 NEWS
About Michael Zand

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.